文献速递腹部介入MRCT

肝定向放射治疗后钆塞酸增强MRI上正常肝实质信号强度变化的特征与预测

Characterization and Prediction of Signal Intensity Changes in Normal Liver Parenchyma on Gadoxetic Acid-enhanced MRI Scans after Liver-directed Radiation Therapy.
PubMed 文献 · Radiol Imaging Cancer · 2022-01-01

本回顾性研究纳入100例因肝细胞癌、胆管肿瘤或肝转移瘤接受放射治疗的患者,在放疗后1-6个月和6-12个月行钆塞酸增强MRI肝胆期检查,发现多数患者出现局灶性肝脏反应(FLR),其体积随时间减小;FLR形成的中位生物学有效剂量阈值在1-6个月为63.6 Gy、6-12个月为88.7 Gy,且FLR体积与1-6个月ALBI评分升高显著相关(P = .048)。

要点

  • 放疗后1-6个月FLR形成的中位BED阈值为63.6 Gy,6-12个月为88.7 Gy。
  • 多数患者出现FLR,且FLR体积随时间减小。
  • FLR体积与1-6个月ALBI评分升高显著相关(P = .048)。

核心结论

  • FLR是放疗后肝损伤的明确指标,与肝功能障碍和局灶性放射性肝病的发生相关。

研究设计与样本

  • 回顾性研究,纳入100例患者(中位年龄65岁,四分位距60-69岁;80例男性),2018年3月1日至2020年2月29日在西奈山医院因肝细胞癌、胆管肿瘤或肝转移瘤接受放疗;将CT模拟扫描与放疗后1-6个月和6-12个月的行钆塞酸增强MRI肝胆期图像融合;由两名放射肿瘤科医生独立勾画放疗区域MRI低信号边界以定义FLR体积。

关键影像表现/征象

  • 放疗区域在MRI肝胆期表现为低信号,据此勾画FLR边界。
  • 多数患者出现FLR,且FLR体积随时间减小。
  • 7例 explanted 肝脏标本的组织病理学分析显示与放射性肝病一致的发现。

诊断标准与关键数值

  • FLR形成的中位BED阈值:1-6个月为63.6 Gy,6-12个月为88.7 Gy。
  • FLR体积与1-6个月ALBI评分升高显著相关(P = .048)。
  • 基线ALBI评分较高与FLR发生率较低相关。
  • 队列12个月和24个月生存估计分别为81%和48%。

临床应用与阅片要点

  • 在放疗后1-6个月和6-12个月的行钆塞酸增强MRI肝胆期图像上,应关注放疗区域出现的低信号,即FLR。
  • FLR体积可用于评估放疗后肝损伤程度,并与肝功能障碍相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To better characterize and understand the significance of focal liver reaction (FLR) development in a large cohort of patients who underwent gadoxetic acid-enhanced MRI after being treated with radiation therapy (RT) for hepatobiliary tumors. Materials and Methods This retrospective study evaluated 100 patients (median age, 65 years [first and third quartiles, 60-69 years]; 80 men) who underwent RT for hepatocellular carcinoma, bile duct tumors, or liver metastases at Mount Sinai Hospital between March 1, 2018, and February 29, 2020. CT simulation scans were fused to MRI scans obtained 1-6 months and 6-12 months after RT, using the hepatobiliary phase of the MRI. To define FLR volume, two radiation oncologists independently delineated the borders of the hypointensity observed on MRI scans in the liver region where RT was delivered. Biologically effective dose (BED) thresholds for the formation of FLRs were calculated, along with albumin-bilirubin (ALBI) scores and grades, and overall survival. Results Most patients developed FLRs, which decreased in volume over time. Median BED threshold values for FLR development were 63.6 Gy at 1-6 months and 88.7 Gy at 6-12 months. While higher baseline ALBI scores were associated with a lower rate of FLRs, there was a significant association between FLR volume and increase in ALBI score at 1-6 months (P = .048). Twelve- and 24-month survival estimates for the cohort were 81% and 48%, respectively. Histopathologic analysis of seven explanted liver specimens demonstrated findings consistent with radiation-induced liver disease. Conclusion FLRs were a clear measure of liver damage after RT and were associated with the development of liver dysfunction and focal radiation-induced liver disease. Keywords: MRI, Radiation Therapy Supplemental material is available for this article. © RSNA, 2022.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Nehlsen AD, Sindhu KK, Wolken T, et al. Characterization and Prediction of Signal Intensity Changes in Normal Liver Parenchyma on Gadoxetic Acid-enhanced MRI Scans after Liver-directed Radiation Therapy. Radiol Imaging Cancer. 2022. PMID: 35904411. doi:10.1148/rycan.210100

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。